News tagged with clinical pathway
New method to grow arteries could lead to 'biological bypass' for heart disease
A new method of growing arteries could lead to a "biological bypass"—or a non-invasive way to treat coronary artery disease, Yale School of Medicine researchers report with their colleagues in the April issue of Journal of ...
Medicine & Health / Medical research
Mar 08, 2010 |
4.1 / 5 (7) |
0
|
Loss of 'guardian angel' gene prompts premature birth
Mutation of a gene that helps protect the body from genetic instability leads to cellular and molecular changes in the pregnant uterus that trigger premature birth, according to a study appearing online Feb. ...
Feb 01, 2010 |
5 / 5 (2) |
0
All-nighters can bring on euphoria, risky behavior
(PhysOrg.com) -- A sleepless night can make us cranky and moody. But a lesser known side effect of sleep deprivation is short-term euphoria, which can potentially lead to poor judgment and addictive behavior, ...
Medicine & Health / Neuroscience
Mar 23, 2011 |
5 / 5 (2) |
1
|
Scientists show Six3 gene essential for retinal development
New research led by St. Jude Children's Research Hospital investigators adds to evidence that the Six3 gene functions like a doorman in the developing brain and visual system, safeguarding the future retina by keeping the ...
Sep 20, 2010 |
4 / 5 (2) |
0
Wistar researchers show targeting 'normal' cells in tumors slows growth
Targeting the normal cells that surround cancer cells within and around a tumor is a strategy that could greatly increase the effectiveness of traditional anti-cancer treatments, say researchers at The Wistar Institute.
Nov 16, 2009 |
3 / 5 (2) |
0
Researchers uncover hormone pathway to fatty liver disease
Scientists at the UCSF Cardiovascular Research Institute have discovered how a change in growth hormone activity in mice leads to fatty liver disease, a condition whose human counterpart is of rising concern worldwide.
Medicine & Health / Medical research
Mar 01, 2011 |
5 / 5 (1) |
0
BATTLE links potential biomarkers to drugs for lung cancer
The first lung cancer clinical trial to guide targeted therapies to patients based on molecular signatures in tumor biopsies is a step toward personalized care and more effective, efficient clinical trials for new drugs, ...
Apr 19, 2010 |
4 / 5 (1) |
0
